Puri S, Baker B L, Dutka D P, Oakley C M, Hughes J M, Cleland J G
Department of Medicine (Clinical Cardiology and Respiratory Medicine), Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
Circulation. 1995 Jun 1;91(11):2769-74. doi: 10.1161/01.cir.91.11.2769.
The pulmonary diffusing capacity for carbon monoxide (DLCO) is reduced in chronic heart failure (CHF) and is an independent predictor of peak exercise oxygen uptake. The pathophysiological basis for this remains unknown. The aim of this study was to partition DLCO into its membrane conductance (DM) and capillary blood volume components (Vc) and to assess if alveolar-capillary membrane function correlated with functional status, exercise capacity, and pulmonary vascular resistance.
The classic Roughton and Forster method of measuring single-breath DLCO at varying alveolar oxygen concentrations was used to determine DM and Vc in 15 normal subjects and 50 patients with CHF. All performed symptom-limited maximal bicycle exercise tests with respiratory gas analysis; 15 CHF patients underwent right heart catheterization. DLCO was significantly reduced in CHF patients compared with normal subjects, predominantly because of a reduction in DM (7.0 +/- 2.6 versus 12.9 +/- 3.8 versus 20.0 +/- 6.1 mmol.min-1.kPa-1 in New York Heart Association class III, class II, and normal subjects, respectively, P < .0001), even when the reduction in lung volumes was accounted for by the division of DM by the effective alveolar volume. The Vc component of DLCO was not impaired. DM significantly correlated with maximal exercise oxygen uptake (r = .72, P < .0001) and inversely correlated with pulmonary vascular resistance (r = .65, P < .01) in CHF.
Reduced alveolar-capillary membrane diffusing capacity is the major component of impaired pulmonary gas transfer in CHF, correlating with maximal exercise capacity and functional status. DM may be a useful marker for the alveolar-capillary barrier damage induced by raised pulmonary capillary pressure.
慢性心力衰竭(CHF)患者的肺一氧化碳弥散量(DLCO)降低,且是运动峰值摄氧量的独立预测指标。其病理生理基础尚不清楚。本研究的目的是将DLCO分为膜传导率(DM)和毛细血管血容量成分(Vc),并评估肺泡-毛细血管膜功能是否与功能状态、运动能力和肺血管阻力相关。
采用经典的Roughton和Forster方法,在不同肺泡氧浓度下测量单次呼吸DLCO,以确定15名正常受试者和50名CHF患者的DM和Vc。所有受试者均进行了症状限制的最大运动自行车试验并进行呼吸气体分析;15名CHF患者接受了右心导管检查。与正常受试者相比,CHF患者的DLCO显著降低,主要是由于DM降低(纽约心脏协会III级、II级和正常受试者的DM分别为7.0±2.6、12.9±3.8和20.0±6.1 mmol·min-1·kPa-1,P<.0001),即使通过将DM除以有效肺泡容积来校正肺容积减少的影响。DLCO的Vc成分未受损。在CHF患者中,DM与最大运动摄氧量显著相关(r=.72,P<.0001),与肺血管阻力呈负相关(r=.65,P<.01)。
肺泡-毛细血管膜弥散能力降低是CHF患者肺气体交换受损的主要因素,与最大运动能力和功能状态相关。DM可能是肺毛细血管压力升高所致肺泡-毛细血管屏障损伤的有用标志物。